$RTON Right on Brands (RTON) Signs Exclusive Distribution

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Enhancing Investor Rights in Ibotta, Inc. Class Action The Rosen Law Firm, recognized for its commitment to global investor rights, is reaching out to purchasers of Ibotta, Inc. (NYSE: IBTA) regarding the recent developments surrounding its initial public offering (IPO). Investors who participated in the IPO may have the chance to be part of a class action lawsuit that...

GETESA and Comviva Join Forces to Revolutionize Digital Payments GETESA Money S.A., a prominent subsidiary of GETESA, is set to introduce pioneering digital payment services using Comviva's mobiquity® Pay platform. This strategic partnership marks a significant step towards enhancing digital financial transactions, aiming to foster a cash-lite economy. Innovative Payment...

Understanding the Semiconductor Landscape Investors and analysts alike are continually on the lookout for valuable insights in the ever-changing landscape of the semiconductor industry. A closer examination of key players, such as Monolithic Power Systems (NASDAQ: MPWR), can reveal a lot about market trends and company performance. By comparing financial metrics and...

SendCutSend Drives Business Growth with Innovative Tools SendCutSend has positioned itself as a key player in American manufacturing by offering robust enterprise features for various industries. The company is experiencing a significant surge in demand for its tailored business tools that cater specifically to the needs of engineering teams, purchasing departments, and...

SciBase Holding AB (STO: SCIB) has stirred the pot with its latest claims about Nevisense and atopic dermatitis predictions—this study hit the radar on February 17, 2026. It’s set to be presented at the AAAAI conference from February 27 to March 2. Sounds like a breakthrough, right? Well, let’s dissect what this really means for traders sitting on that stock....